Emboline, Inc. is a medical device company based in the San Francisco Bay Area. Emboline is developing embolic protection solutions to address the unmet need for embolic debris capture and removal during transcatheter heart procedures that can otherwise cause stroke and other organ damage.
Location: United States
Employees: 1-10
Total raised: $95M
Investors 4
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | SV Tech Ve... | svtechvent... |
| - | Aimtop Ven... | aimtopvc.c... |
| - | Anthro Ven... | anthrovent... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 11.03.2026 | - | $20M | Trinity Ca... |
| 25.05.2021 | Series D | $55M | - |
| 05.01.2021 | Series C | $10M | - |
| 19.04.2018 | - | $10M | - |
Mentions in press and media 12
| Date | Title | Description |
| 13.03.2026 | Emboline Secures $20M: Emboliner System Nears Market Launch | Emboline, a Santa Cruz medtech innovator, secured $20 million from Trinity Capital. This growth capital fuels the commercial launch of its Emboliner Embolic Protection System. The device offers crucial protection. It prevents stroke and vit... |
| 11.03.2026 | Emboline: $20 Million Raised For Embolic Protection Technology Platform | Emboline, a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart procedures, has secured $20 million in growth capital from Trinity Capital. The financing will support the commerci... |
| 11.03.2026 | Emboline Raises $20M in Growth Capital from Trinity Capital | Emboline, Inc., a Santa Cruz, CA-based privately held medical technology company, raised $20M in growth capital. Trinity Capital made the investment. The company intends to use the funds to support its upcoming commercial launch activities ... |
| 25.05.2021 | Emboline Raises over $55 Million in Series D Funding for Pivotal FDA Clinical Study and Market Launch of the Emboliner™ Embolic Protection Catheter to Minimize Stroke Risk from TAVR | |
| 25.05.2021 | Emboline Raises over $55 Million in Series D Funding for Pivotal FDA Clinical Study and Market Launch of the Emboliner™ Embolic Protection Catheter to Minimize Stroke Risk from TAVR | SANTA CRUZ, Calif., May 25, 2021 /PRNewswire/ -- Emboline, Inc., a privately held medical device company focused on reducing stroke and other damage caused by embolic debris released during transcatheter heart procedures, today announced th... |
| 25.05.2021 | Emboline Raises Over $55M in Series D Funding | Emboline, Inc., a Santa Cruz, Calif.-based medical device company focused on reducing stroke and other damage caused by embolic debris released during transcatheter heart procedures, closed its Series D funding of over $55m. The round was l... |
| 06.01.2021 | Daily funding roundup - January 5th, 2021 | Blue Wire raised $5M; Emboline landed $10M; PostHog secured $12M; Citizen pickes up $73M Care Package Direct: Care Package Direct was founded during the pandemic with the intent to make health and safety surveillance and supplies as simple ... |
| 05.01.2021 | Emboline Nabs $10M Series C Financing | SANTA CRUZ, CA, Emboline today announced it completed raising over $10 million in Series C funding. >> Click here for more funding data on Emboline >> To export Emboline funding data to PDF and Excel, click here Emboline,... |
| 05.01.2021 | Emboline™ Raises Over $10 Million in Series C Funding to Fund Further Development of the Emboliner™ Embolic Protection Catheter to Minimize Stroke Risk From TAVR | |
| 05.01.2021 | Emboline Raises Over $10M in Series C Funding | Emboline, Inc., a Santa Cruz, CA-based medical technology company focused on reducing stroke during transcatheter heart procedures, completed an over $10m in Series C funding. Backers included new and existing investors. The company intends... |
Show more